Skip to main content.

Shellie D. Ellis, M.A., Ph.D.

Shellie Ellis portrait
Associate Professor, Population Health

Director of Metrics and Evaluation, Frontiers: The Heartland Institute for Clinical and Transactional Research

sellis4@kumc.edu

Professional Background

Shellie Ellis, MA, PhD, is a health services researcher and implementation scientist focused on improving care delivery.

Dr. Ellis has graduate training in medical anthropology and health services research and was awarded an NCI-funded Mentored Training in Dissemination and Implementation Research in Cancer (MT-DIRC) fellowship in 2016. She has received funding from NCI, NIA, NIGMS, PCORI, and several foundations and organizations. She serves on national study sections as an implementation scientist and is Associate Editor of the new international journal Implementation Science Communications.

Dr. Ellis has 20 years of experience implementing evidence-based research in practice. She has implemented both screening and treatment interventions in a variety of primary and specialty settings, spanning federally qualified health centers, hospital-owned outpatient clinics and private practices in rural, urban and suburban settings. She has designed implementation strategies to promote evidence-based practice in both primary care and specialty care practices and conducted multiple studies to assess determinants of healthcare provider adoption and implementation of evidence-based practice.

Education and Training
  • BA, Journalism, University of Oklahoma, Norman, OK
  • MA, Anthropology, Wake Forest University, Winston-Salem, NC
  • Other, Mathematics-Statistics, University of North Carolina, Greensboro, Greensboro, NC
  • PhD, Health Policy and Management, University of North Carolina, Chapel Hill
  • Other, Implementation Science, Washington University, St. Louis, St. Louis, MO

Research

Overview

My current work focuses on understanding and guiding the adoption of evidence-based cancer innovations among cancer specialty providers, particularly cancer care providers practicing in urologic, non-academic, and rural settings. I am currently principal investigator of LEARN|INFORM|RECRUIT, a multi-modal intervention facilitating community urologists’ adherence to treatment guidelines and Precision Community, a NIGMS-funded project to understand determinants of community oncologists’ use of precision medicine in cancer treatment (precisioncommunity@kumc.edu). I served as the 2019-20 Visiting Scholar to the NCI’s Cancer Care Delivery Branch collaborating with NCI staff to identify and understand rural oncology practices’ participation in cancer care delivery research. I am co-investigator on several federally funded projects to implement evidence-based practices into clinical care.

Publications
  • Ellis, Shellie., D, Geana, Mugur, Griebling, Tomas, McWilliams, Charles, Gills, Jessie , Stratton, Kelly, Mackay*, Christine, Shifter*, Ariel, Zganjar*, Andrew, Thrasher, J.., Brantley. 2019. Development, acceptabilty, appropriateness and appeal of a cancer clinical trials facilitated toolkit for rural- and minority-serving practices. Trials, 20 (578). https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-019-3658-z
  • Ellis, Shellie., D, Geana, Mugur, Mackay*, C., B, Moon*, D., J, Gills, J, Zganjar*, A, Brekke*, G, Thrasher, J., B, Griebling, T., L. 2019. Science in the Heartland: Exploring determinants of offering cancer clinical trials in rural-serving community urology practices.. Urologic Oncology, 37 (8), 519-564
  • Ellis, S., D, Chen, R., C, Dusetzina, S., B, Wheeler, S., B, Jackson, G., L, Nielsen, M., E, Carpenter, W., R, Weinberger, M. 2016. Are Small Reimbursement Changes Enough to Change Cancer Care? Reimbursement Variation in Prostate Cancer Treatment.. Journal of oncology practice, 12 (4), e423-36
  • Ellis, S., D, Nielsen, M., E, Carpenter, W., R, Jackson, G., L, Wheeler, S., B, Liu, H, Weinberger, M. 2015. Gonadotropin-releasing hormone agonist overuse: urologists' response to reimbursement and characteristics associated with persistent overuse.. Prostate cancer and prostatic diseases, 18 (2), 173-81
  • Ellis, S., D, Blackard, B, Carpenter, W., R, Mishel, M, Chen, R., C, Godley, P., A, Mohler, J., L, Bensen, J., T. 2013. Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North Carolina.. Cancer, 119 (12), 2282-90
  • Mackay*, Christine., B, Antonelli, K., R, Bruinooge, S., S, Saint Onge, J., M, Ellis, S., D. 2017. Insurance denials for cancer clinical trial participation after the Affordable Care Act mandate.. Cancer, 123 (15), 2893-2900
  • Ellis, S., D, Carpenter, W., R, Minasian, L., M, Weiner, B., J. 2012. Effect of state-mandated insurance coverage on accrual to community cancer clinical trials.. Contemporary clinical trials, 33 (5), 933-41
  • Ellis, S., D, Bertoni, A., G, Bonds, D., E, Clinch, C., R, Balasubramanyam, A, Blackwell, C, Chen, H, Lischke, M, Goff, Jr, D., C. 2007. Value of recruitment strategies used in a primary care practice-based trial.. Contemporary clinical trials, 28 (3), 258-67
  • Gondi, Saahith, Ellis, Shellie, Gupta, Mallika, Ellerbeck, Edward, Richter, Kimber, Burns, Jeffrey, Gupta, Aditi. 2021. Physician perceived barriers and facilitators for self-measured blood pressure monitoring- a qualitative study. PLOS ONE, 16 (8)
  • Birken, S., A, Ellis, S., D, Walker, J., S, DiMartino, L., D, Check, D., K, Gerstel, A., A, Mayer, D., K. 2015. Guidelines for the use of survivorship care plans: a systematic quality appraisal using the AGREE II instrument.. Implementation science : IS, 10, 63